Healthtech supply chains are under new pressure from tariffs, traceability requirements, geopolitical risk and sustainability expectations. For leaders in medical devices, biopharma and diagnostics, resilience increasingly means building flexible, transparent supply networks that can adapt without compromising quality, access or long-term value.
As intelligent technologies reshape healthcare, priorities like cybersecurity, governance and trusted decision-making are critical for organizations seeking to innovate, scale and earn lasting confidence.
As intelligent technologies reshape healthcare, priorities like cybersecurity, governance and trusted decision-making are critical for organizations seeking to innovate, scale and earn lasting confidence.
As intelligent technologies reshape healthcare, priorities like cybersecurity, governance and trusted decision-making are critical for organizations seeking to innovate, scale and earn lasting confidence.
Interoperability, AI-ready data platforms, and real-world evidence are becoming essential competitive advantages as healthtech companies work to prove value, support adoption, and compete in a more connected, outcomes-driven market.
Discover how health tech leaders are building the infrastructure to scale, deliver, and prove the value of breakthrough treatments, from advanced therapies like cell and gene, mRNA, and radiopharmaceuticals to the devices, diagnostics, and data systems making them viable.
AI-enabled diagnostics and clinical decision support are becoming core competitive differentiators in 2026, shifting from passive tools to active partners in detection, workflow optimization, and precision care across medtech, diagnostics, and digital health.
AI-powered hybrid and hospital-at-home care are moving from pilot programs to core operating models in 2026, reshaping care delivery, workforce strategy, and competitive advantage across health tech.